Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

973 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Asparagus polysaccharide and gum with hepatic artery embolization induces tumor growth and inhibits angiogenesis in an orthotopic hepatocellular carcinoma model.
Weng LL, Xiang JF, Lin JB, Yi SH, Yang LT, Li YS, Zeng HT, Lin SM, Xin DW, Zhao HL, Qiu SQ, Chen T, Zhang MG. Weng LL, et al. Among authors: lin jb, lin sm. Asian Pac J Cancer Prev. 2014;15(24):10949-55. doi: 10.7314/apjcp.2014.15.24.10949. Asian Pac J Cancer Prev. 2014. PMID: 25605207 Free article.
A real-world study to evaluate effectiveness of mepolizumab in treating severe asthma in Taiwan (REMIT).
Cheng SL, Lin SM, Peng CK, Chan MC, Shen SY, Kuo PH, Lai CH, Lan CC, Chen CY, Lin CH, Liao KM, Feng PH, Wu JT, Wei YF, Xu X, Alfonso-Christancho R, Lai T, Navarro A, Milea D, Perng DW. Cheng SL, et al. Among authors: lin sm. Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666241308406. doi: 10.1177/17534666241308406. Ther Adv Respir Dis. 2025. PMID: 39829048
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.
Sangro B, Kudo M, Erinjeri JP, Qin S, Ren Z, Chan SL, Arai Y, Heo J, Mai A, Escobar J, Lopez Chuken YA, Yoon JH, Tak WY, Breder VV, Suttichaimongkol T, Bouattour M, Lin SM, Peron JM, Nguyen QT, Yan L, Chiu CF, Santos FA, Veluvolu A, Thungappa SC, Matos M, Żotkiewicz M, Udoye SI, Kurland JF, Cohen GJ, Lencioni R; EMERALD-1 Investigators. Sangro B, et al. Among authors: lin sm. Lancet. 2025 Jan 18;405(10474):216-232. doi: 10.1016/S0140-6736(24)02551-0. Epub 2025 Jan 8. Lancet. 2025. PMID: 39798579 Clinical Trial.
973 results